Posluma (flotufolastat F 18)
Prostate Cancer (suspected recurrence/metastasis)
ApprovedActive
Key Facts
Indication
Prostate Cancer (suspected recurrence/metastasis)
Phase
Approved
Status
Active
Company
About Blue Earth Diagnostics
Blue Earth Diagnostics is a commercial-stage, private diagnostics company specializing in targeted radiopharmaceuticals for cancer imaging. It leverages a proven track record in rapid development and commercialization to bring novel PET imaging agents to market, aiming to transform clinical decision-making in oncology. As part of the Bracco family, it benefits from global commercial infrastructure and expertise, with a pipeline focused on expanding into new cancer indications. The company's strategy centers on applying its molecular imaging knowledge to drive future therapeutic advancements.
View full company profile